AstraZeneca’s blood cancer drug meets main goal in late-stage trial

Life Science

CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC

Life Science

Shanghai’s EpimAb Completes $74 Million Series B for Bi-Specific Antibodies

Life Science

BioMarin’s Very-Rare Disease Treatment Approved in China

Life Science

Canopy wants hemp operations in seven states within 12 months

Cannabis, Life Science

CVS to open 1,500 HealthHUB stores over next two years

Life Science

Frontage Holdings Corporation Celebrates a Successful Initial Public Offering on the HKEx

Life Science

Jiangsu Provincial Institute of Materia Medica Selects Provantis Preclinical SaaS Solution

Life Science

Innovent Reports Data on Four China Trials of Approved PD-1 Drug

Life Science

Medical Marijuana, Inc. Announces International Coverage at FDA Public Hearing on Cannabis and CBD Products  

Cannabis, Life Science

AstraZeneca and Merck to Seek Regulatory Approval for Lynparza in Pancreatic Cancer

Life Science

CStone submits new drug application for TIBSOVO(R) in Taiwan for the treatment of relapsed/refractory AML

Life Science

HitGen Forms Drug Discovery Partnership with Gilead Sciences

Life Science

Hitachi Signs Contract with HIMED Xuzhou City, Jiangsu Province, China to Deliver Particle Therapy System  

Life Science

BGI Americas Opens Mass Spectrometry Center in California

Life Science